The report highlights Hisamitsu Pharmaceutical Group's commitment to sustainable growth through its financial and non-financial efforts. It details the company's new mission ""Promoting 'TE-A-TE' Culture Worldwide"" and outlines the 7th Mid-Term Management Policy (HX2025) for FY2021 to FY2025. Specific achievements include the launch of Zicthoru® Tape for cancer pain management, the Kiyohara Industrial Park Smart Energy Project at the Utsunomiya Factory for energy conservation, and the company's dedication to the Japanese Red Cross Society in disaster relief efforts.
Issuing Company Hisamitsu Pharmaceutical Co. Inc.
Report Type Integrated Report
Report Language EN
Report Filesize 7.41 MB
No. of Pages 22 pages
Reporting periodMarch 1, 2020-February 28, 2021
Report EditionUnknown
Assurance Provider Unknown
Reporting Standards GRI; SASB; UNSDGs
Materiality Assessmenttrue
